2022 MCM | How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
George R. Simon, MD, FACP, FCCP
Date of Release
May 14th, 2025
-1762274923981.webp&w=3840&q=75)
-1760723320622.webp&w=3840&q=75)